Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Chemie-Wirtschaftsförderungsgesellschaft
Friedrich-Alexander-Universität Erlangen-Nürnberg
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 20 November 2024
First Online: 29 November 2024
Declarations
:
: E. Leibold is employed by BASF SE, a manufacturer of UV-P; however, BASF SE was not involved in the design of the study nor in the evaluation or interpretation of results. C. Fischer, J. Hiller, and T. Göen have no conflicts of interest to declare.
: The study has been approved by the ethics committee of the medical faculty of Friedrich-Alexander-Universität Erlangen-Nürnberg (22-329-B) and has been performed in accordance with all relevant ethical standards. All study participants gave their written and informed consent to participate in the study prior to inclusion.
